Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-03

Clinical Trial Update: A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two fluticasone furoate nasal sprays for seasonal allergic rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone furoate nasal spray (two formulations) (fluticasone furoate nasal spray)

Snippet

Sponsor: Sandoz | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED | Results posted: 2021-02-03